New Zealand
Clinicians reminded to be aware of myocarditis and pericarditis symptoms in NZ
The CV-ISMB extends their sympathies to the woman’s family and friends during this difficult time and thanks the family for their assistance with thi...
August 31, 2021 | News
Pharmac to fund new cardiovascular medicine with amended Special Authority criteria
People with at high-risk of cardiovascular disease, who meet the funding criteria, will be able to access funded rosuvastatin from 1 December 2021. &ldquo...
August 29, 2021 | News
New Zealand approved YishengBio COVID-19 vaccine trials
YishengBio is a biopharmaceutical company focusing on discovery, development, manufacturing and commercialization of new generations of vaccines and therap...
August 10, 2021 | News
Alvotech initiates clinical studies for AVT04, a proposed biosimilar to Stelara
Alvotech, today, announced that the first patient has been dosed in the comparative, confirmatory efficacy and safety clinical study (AVT04-GL-301) for AVT...
July 06, 2021 | News
Zimmer Biomet announces partnership with OSSIS
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced a partnership with OSSIS to serve as the e...
July 01, 2021 | News
Sermo Acquires Minter Group to connect the pharmaceutical industry In APAC
Sermo, the world’s leading HCP insights company and the first social media platform for physicians, today announced its acquisition of Australia-base...
June 15, 2021 | News
Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand
llumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of So...
June 01, 2021 | News
BioFactura Announces Initiation of Phase I Study of BFI-751, a Stelara® Biosimilar
First clinical trial from BioFactura’s pipeline of high-value biosimilar and biodefense drugs BFI-751: Biosimilar designed to treat people with Cr...
June 01, 2021 | News
Most Read
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
